Updates are available Correction dated 2020-01-31
Click to view Correction: https://doi.org/10.1038/s41580-020-0219-y
-
Authors
Liu, Grace Y. https://orcid.org/0000-0001-5463-3055
Sabatini, David M. https://orcid.org/0000-0002-1446-7256
- License Information
-
More Information
Article History
Accepted: 26 November 2019
First Online: 14 January 2020
Change Date: 31 January 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41580-020-0219-y
Competing interests
: D.M.S. is a founder and a member of the scientific advisory board for Navitor Pharmaceuticals, which targets the mTORC1 pathway for therapeutic benefit.
